Cyphostemmic acid B - Compound Card

Cyphostemmic acid B

Select a section from the left sidebar

Cyphostemmic acid B

Structure
Zoomed Structure
  • Family: Plantae - Vitaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene
Canonical Smiles OC[C@H]1[C@H](O)C(C2[C@@]1(C)C1CCC3[C@@]([C@@]1(CC2)C)(CO)CC[C@@]1(C3[C@@H](CC1)C(=C)C)C(=O)O)(C)C
InChI InChI=1S/C30H48O5/c1-17(2)18-9-12-29(25(34)35)13-14-30(16-32)19(23(18)29)7-8-22-27(30,5)11-10-21-26(3,4)24(33)20(15-31)28(21,22)6/h18-24,31-33H,1,7-16H2,2-6H3,(H,34,35)/t18-,19?,20-,21?,22?,23?,24-,27+,28-,29-,30-/m0/s1
InChIKey VSZHYEJHFMOKBY-CFNWBEDGSA-N
Formula C30H48O5
HBA 4
HBD 4
MW 488.71
Rotatable Bonds 4
TPSA 97.99
LogP 4.89
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 35
Formal Charge 0
Fraction CSP3 0.9
Exact Mass 488.35
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Cyphostemma adenocaule Vitaceae Plantae 1236437

Showing of synonyms

  • Chouna JR, Nardella F, et al. (2016). Ceanothane-type triterpenoids from Cyphostemma adenocaule.. Archives of pharmacal research,2016. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCC(C12)CCC3C2CCC4C5C(CCC5)CCC34

Level: 0

Mol. Weight: 488.71 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.61
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.970
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.93

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.580
Plasma Protein Binding
79.78
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
4.210
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.720
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.120
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.960
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-303.850
Rat (Acute)
2.640
Rat (Chronic Oral)
2.850
Fathead Minnow
3.970
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
476.990
Hydration Free Energy
-2.840
Log(D) at pH=7.4
2.960
Log(P)
3.94
Log S
-4.85
Log(Vapor Pressure)
-10.51
Melting Point
251.61
pKa Acid
4.87
pKa Basic
7.59
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Sulfotransferase 2A1 Q06520 ST2A1_HUMAN Homo sapiens 3 0.8068
Branched-chain-amino-acid aminotransferase, mitochondrial O15382 BCAT2_HUMAN Homo sapiens 3 0.7839
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7559
Cytochrome P450 monooxygenase Q5YNS8 Q5YNS8_NOCFA Nocardia farcinica 3 0.7432
Deacetoxycephalosporin C synthase P18548 CEFE_STRCL Streptomyces clavuligerus 3 0.7366
Vitamin D-binding protein P02774 VTDB_HUMAN Homo sapiens 2 0.7139
Sulfotransferase 2B1 O00204 ST2B1_HUMAN Homo sapiens 2 0.7032

Download SDF